Search results for " ExPEC"

showing 10 items of 304 documents

Lesión medular y ejercicio físico: revisión desde una perspectiva deportiva

2016

Una de cada 2000 personas en Europa tiene lesión medular (LM), es normalmente más sedentaria que el resto de la población y encuentra diferentes problemas para practicar ejercicio físico (EF), destacando la escasa formación específica de los profesionales del deporte. Con el objetivo de aportar información sobre la LM y su interacción con la práctica deportiva, se realizó una revisión de literatura científica que analiza sus alteraciones músculoesqueléticas, cardiovasculares, respiratorias, de termorregulación, genitourinarias e intestinales, las úlceras por presión, la disreflexia autonómica y los aspectos nutricionales, generando recomendaciones prácticas. Como conclusión, la práctica hab…

0106 biological sciences030506 rehabilitationmedicine.medical_specialtyPhysical fitnessPopulationPhysical exerciseactividad física01 natural scienceslcsh:Social Sciences03 medical and health sciencesQuality of life (healthcare)medicinedeporte.lcsh:Social sciences (General)educationSpinal cord injuryParaplejiaeducation.field_of_studybusiness.industry010604 marine biology & hydrobiologyIncidence (epidemiology)General Medicinemedicine.diseaselcsh:HLife expectancyPhysical therapytetraplejiaAutonomic dysreflexialcsh:H1-990305 other medical sciencebusinessRevista Española de Discapacidad
researchProduct

Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms

2017

Life expectancy and the number of elderly people are progressively increasing around the world. Together with other pathologies, allergic diseases also show an increasing incidence in geriatric age. This is partly due to the growing emphasis on a more accurate and careful diagnosis of the molecular mechanisms that do not allow to ignore the real pathogenesis of many symptoms until now unknown, and partly to the fact that the allergic people from 20 years ago represent the elderly population now. Moreover, environmental pollution predisposes to the onset of allergic asthma and dermatitis which are the result of internal pathologies more than the expression of allergic manifestations. At the …

0301 basic medicineAgingAllergyAllergyUrticariamedicine.medical_treatmentImmunologyEnvironmental pollutionReviewSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesElderlyImmune systemAnaphylaxiFood allergyFood allergymedicineImmunology and AllergyAnaphylaxisMolecular BiologyAsthmabusiness.industryConjunctivitiImmunotherapyConjunctivitismedicine.diseaseAsthmaDrug reaction030104 developmental biologyageAging; Allergy; Anaphylaxis; Asthma; Conjunctivitis; Drug reaction; Elderly; Food allergy; Immunotherapy; Urticaria; Immunology and Allergy; Immunology; Molecular BiologyImmunologyLife expectancyImmunotherapybusinessAnaphylaxisClinical and Molecular Allergy
researchProduct

Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study

2019

<b><i>Objective:</i></b> Older people approaching the end of life are at a high risk for adverse drug reactions. Approaching the end of life should change the therapeutic aims, triggering a reduction in the number of drugs.<b><i></i></b>The main aim of this study is to describe the preventive and symptomatic drug treatments prescribed to patients discharged with a limited life expectancy from internal medicine and geriatric wards. The secondary aim was to describe the potentially severe drug-drug interactions (DDI). <b><i>Materials and Methods:</i></b> We analyzed Registry of Polytherapies Societa Italiana di Medicina I…

0301 basic medicineDrugMalemedicine.medical_specialtyDeprescriptions020205 medical informaticsDrug-Related Side Effects and Adverse Reactionsmedia_common.quotation_subjectElderly; End of life; Limited life expectancy; Polypharmacy; Symptomatic medications; Aged 80 and over; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Italy; Male; Polypharmacy; Deprescriptions; Life Expectancy; Patient DischargeSocio-culturale02 engineering and technology03 medical and health sciencesElderly · End of life · Limited life expectancy · Polypharmacy · Symptomatic medicationsPharmacotherapyDeprescriptionsLife ExpectancyElderlySymptomatic medications0202 electrical engineering electronic engineering information engineeringmedicine80 and overHumansLS4_4Medical prescriptionElderly; End of life; Limited life expectancy; Polypharmacy; Symptomatic medicationsmedia_commonAgedPolypharmacyAged 80 and overOriginal Paperbusiness.industryGeneral MedicineElderly End-of-life Limited life expectancy Polypharmacy Preventing medications Symptomatic medicationsElderly End of life Limited life expectancy Polypharmacy Symptomatic medicationsPatient DischargeClonidineLimited life expectancyItalyEmergency medicineEnd of lifeLife expectancyPolypharmacyFemale030101 anatomy & morphologyDeprescribingbusinessmedicine.drugSymptomatic medication
researchProduct

Extraintestinal pathogenic Escherichia coli sequence type 131 H30-R and H30-Rx subclones in retail chicken meat, Italy

2016

Extraintestinal pathogenic Escherichia coli sequence type 131 (ST131), typically fluoroquinolone-resistant (FQ-R) and/or extended-spectrum β-lactamase (ESBL)-producing, has emerged globally. Among clinical isolates, ST131, primarily its H30-R and H30-Rx subclones, accounts for most antimicrobial-resistant E. coli and is the dominant E. coli strain worldwide. We assessed its prevalence and characteristics among raw chicken meat samples on sale in Palermo, Italy. A collection of 237 fluoroquinolone resistant and ESBL/AmpC producing E. coli isolates, which had been isolated from processed retail chicken meat in the period May 2013-April 2015, was analyzed. Established polymerase chain reaction…

0301 basic medicineFimH30MeatAFLPST131Settore MED/17 - Malattie InfettiveAnimal foodExtraintestinal Pathogenic Escherichia colichicken030106 microbiologyBiologySettore MED/42 - Igiene Generale E ApplicataMicrobiologyH30-RxMicrobiologylaw.invention03 medical and health sciencesColi strainQuinolone resistanceChicken meatlawDrug Resistance BacterialAnimalsEscherichia coli sequence type 131Amplified Fragment Length Polymorphism AnalysisSafety Risk Reliability and QualityhumansPolymerase chain reactionPhylogenyExPECExtraintestinal Pathogenic Escherichia coliPhylogenetic treeGenetic heterogeneityE. coliGeneral Medicineβ-lactamaseItalyESBLFood MicrobiologyAFLP; Chicken meat; E. coli; ESBL; ExPEC; FimH30; H30-R; H30-Rx; ST131; Food Science; Microbiology; Safety Risk Reliability and QualityE.coliAmplified fragment length polymorphismChickensH30-RFluoroquinolonesPlasmidsFood Science
researchProduct

Nutrigerontology: A key for achieving successful ageing and longevity

2016

During the last two centuries the average lifespan has increased at a rate of approximately 3 months/year in both sexes, hence oldest old people are becoming the population with the fastest growth in Western World. Although the average life expectancy is increasing dramatically, the healthy lifespan is not going at the same pace. This underscores the importance of studies on the prevention of age-related diseases, in order to satisfactorily decrease the medical, economic and social problems associated to advancing age, related to an increased number of individuals not autonomous and affected by invalidating pathologies. In particular, data from experimental studies in model organisms have c…

0301 basic medicineGerontologyAgingMediterranean dietNutrigerontologymedia_common.quotation_subjectAgeing; Longevity; Mediterranean Diet; Nutraceuticals; Nutrigerontology; Phytochemicals; Immunology; AgingPopulationLongevityPhytochemicalsImmunologyClinical nutritionBiologyPhytochemicalSocial issues03 medical and health sciences0302 clinical medicineNutraceuticaleducationmedia_commonSettore MED/04 - Patologia Generaleeducation.field_of_studyMediterranean DietLongevityAgeing030104 developmental biologyEditorialAgeingLife expectancyNutraceuticalNutraceuticals030217 neurology & neurosurgery
researchProduct

Relationship between diet, microbiota, and healthy aging

2020

Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/2227-9059/8/8/287 Este artículo pertenece al número especial "Oxidative stress and inflammation: from mechanisms to therapeutic approaches". En este artículo también participan: Marta Inglés, Gloria Olaso, Juan Gambini y Cristina Mas-Bargues. Due to medical advances and lifestyle changes, population life expectancy has increased. For this reason, it is important to achieve healthy aging by reducing the risk factors causing damage and pathologies associated with age. Through nutrition, one of the pillars of health, we are able to modify these factors through modulation of the intestinal microbiota. The Mediterran…

0301 basic medicineMediterranean dietAging.PopulationMedicine (miscellaneous)PhysiologySalud.ReviewNutrition.General Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineMediterranean dietHigh fatmicrobiotaMedicineMicroorganisms.Healthy agingeducationEnvejecimiento.Beneficial effectslcsh:QH301-705.5Dieta mediterraneapolyphenolseducation.field_of_studyOriental dietbusiness.industryaginghealthMicroorganismos.030104 developmental biologynutritionlcsh:Biology (General)Nutrición.Life expectancyIntestinal bacteriaCookery Mediterranean.businessHealth.030217 neurology & neurosurgeryDieta mediterránea.
researchProduct

Prognosis and cure of long-term cancer survivors: A population-based estimation.

2019

Background: Increasing evidence of cure for some neoplasms has emerged in recent years. The study aimed to estimate population-based indicators of cancer cure. Methods: Information on more than half a million cancer patients aged 15-74 years collected by population-based Italian cancer registries and mixture cure models were used to estimate the life expectancy of fatal tumors (LEFT), proportions of patients with similar death rates of the general population (cure fraction), and time to reach 5-year conditional relative survival (CRS) >90% or 95% (time to cure). Results: Between 1990 and 2000, the median LEFT increased >1 year for breast (from 8.1 to 9.4 years) and prostate cancers (from 5.…

0301 basic medicineOncologyMaleCancer ResearchTime FactorsSettore MED/42 - Igiene Generale E Applicata0302 clinical medicineCancer SurvivorsProstateNeoplasmsThyroid cancerOriginal Researcheducation.field_of_studyRelative survivalMortality rateMiddle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosispopulation-based cancer registriemedicine.anatomical_structureOncologyItaly030220 oncology & carcinogenesiscancer cure Italy population-based cancer registries prevalence survivalFemaleCancer PreventionAdultmedicine.medical_specialtypopulation-based cancer registriesAdolescentPopulationprevalenceSocio-culturalelcsh:RC254-282survival03 medical and health sciencesYoung AdultLife ExpectancyInternal medicinemedicinepopulation‐based cancer registriesHumansRadiology Nuclear Medicine and imagingcancer cureeducationAgedEstimationbusiness.industryCancerModels Theoreticalmedicine.disease030104 developmental biologyLife expectancycancer cure; Italy; population-based cancer registries; prevalence; survivalbusinessCancer medicine
researchProduct

Changes in life expectancy for cancer patients over time since diagnosis

2019

Highlights • Research question: how cancer impacts on LE changes during patients’ entire life • LE increased in patients surviving the first years and decreasing thereafter. • Patients’ LE in the end approached but seldom reached the general population’s LE. • This method describes when cancer survivors’ excess risk of death became negligible. • Life expectancy indicator is easy to be understood and interpreted by patients.

0301 basic medicinePediatricsmedicine.medical_specialtycancer survivorLife expectancyCancer survivorsPopulationYLL years of life lost(ICD-O-3) international classification of diseases for oncology third revisionSocio-culturaleLife expectancy Population-based cancer registry Relative survival Cancer Cancer survivors ItalySettore MED/42 - Igiene Generale E ApplicataRelative survival03 medical and health sciences0302 clinical medicineHealth careMedicineeducationlcsh:Science (General)Population-based cancer registryThyroid cancerCancerRS relative survivaleducation.field_of_studylcsh:R5-920MultidisciplinaryRelative survivalbusiness.industryAbsolute risk reductionCancermedicine.diseaseLE life expectancyNHL non-Hodgkin lymphoma030104 developmental biologyYears of potential life lostItalyISTAT national institute of statistics030220 oncology & carcinogenesisLife expectancy(ICD-10) international classification of diseases tenth revisionOriginal Articlebusinesslcsh:Medicine (General)lcsh:Q1-390Journal of Advanced Research
researchProduct

Extra-Intestinal Fluoroquinolone-Resistant Escherichia coli Strains Isolated from Meat

2018

Extra-intestinal E. coli are emerging as a global threat due to their diffusion as opportunistic pathogens and, above all, to their wide set of antibiotic resistance determinants. There are still many gaps in our knowledge of their origin and spread pathways, although food animals have been adjudicated vehicles for passing mult-drug resistant bacteria to humans. This study analyzed 46 samples of meat purchased from retail stores in Palermo in order to obtain quinolone-resistant E. coli isolates. Strains were screened for their phylogenetic groups, ST131-associated single nucleotide polymorphisms (SNPs), and then typed by ERIC-PCR. Their set of virulence factors, namely, kpsMII, papA, sfaS, …

0301 basic medicineSettore MED/07 - Microbiologia E Microbiologia ClinicaMeatArticle SubjectVirulence Factors030106 microbiologyVirulencelcsh:MedicineSingle-nucleotide polymorphismDrug resistanceMicrobial Sensitivity TestsQuinolonesmedicine.disease_causePolymorphism Single NucleotideGeneral Biochemistry Genetics and Molecular BiologyVirulence factorPoultryMicrobiology03 medical and health sciencesAntibiotic resistanceDrug Resistance Multiple BacterialmedicineEscherichia coliAnimalsEscherichia coliEscherichia coli InfectionsGeneral Immunology and Microbiologybiologylcsh:RGeneral Medicinebiology.organism_classificationAnti-Bacterial AgentsMultiple drug resistanceIntestines030104 developmental biologyFood MicrobiologyE. coli ExPEC foodBacteriaResearch ArticleFluoroquinolonesPlasmids
researchProduct

Why Are New Drugs Expensive and How Can They Stay Affordable?

2019

Increasing life expectancy leading to a higher median age causes an increasing need for healthcare resources, which is aggravated by an increasing prevalence of preventable diseases such as type 2 diabetes. This includes increasing expenditures for medicines, although these increases when expressed as a share of overall societal wealth are more moderate than often claimed. An increasing use of generic medicines (currently about 90% of all prescriptions) means that costs for discovery and development of innovative drugs must be recovered on a shrinking percentage of prescriptions. However, the key challenge to affordable drugs is exponentially increasing costs to bring a new medicine to the …

0301 basic medicinebusiness.industryMedizinmedicine.diseaseA share03 medical and health sciences030104 developmental biology0302 clinical medicineDrug developmentHealth careDevelopment economicsmedicineLife expectancyAttrition030212 general & internal medicineBusinessMedical prescriptionDrug pricing
researchProduct